The power of choice: Why patient optionality is the key to advancing clinical research

This whitepaper explores the significance of the patient optionality evolution in clinical trials, including its ability to overcome longstanding barriers to clinical trial participation and address the need for more diverse representation in research. As the trend for conducting studies outside of the traditional site continues, we are beginning to see a future where sponsors can offer participants a range of visit model options, from mobile clinicians to community sites. Learn why this matters and what this means for the future of research by downloading this whitepaper, which will also discuss the burgeoning landscape for hybrid trial participation models and provide advice for how sponsors can take the next step in implementing participant optionality in trials.